New Immune Defects Linked to Coeliac Disease Risk

by Chief Editor

Researchers at the Snow Centre for Immune Health have identified consistent, subtle defects in immune cell function among people with coeliac disease. Published in Immunology & Cell Biology on June 9, 2026, the study reveals that CD4 helper T cells exhibit slower activation, weaker signaling, and reduced survival, suggesting that autoimmune risk may be embedded in immune cell behavior before clinical symptoms emerge.

How does "immune momentum" change our understanding of autoimmunity?

Traditionally, autoimmunity has been viewed as an overactive immune response. However, the study led by Dr. Vanessa Bryant, Professor Phil Hodgkin, and Dr. Susanne Heinzel challenges this by measuring "immune momentum." Instead of continuously stimulating cells, the team briefly activated T cells and then removed all signals to observe how the cells maintained their response.

From Instagram — related to Cell Timer, Vanessa Bryant

According to Dr. Bryant, this assay acts like "winding up a toy and letting it go to see how long it runs and what tricks it performs." The research, which utilized the Cyton2 Cell Timer model, found that T cells from individuals with coeliac disease produced less interleukin-2 and divided more slowly than expected.

"Our method reveals how well T cells read and store their activation signals to maintain their ‘momentum’ once the original stimulus is gone and whether people with autoimmune disease have built-in differences in how their cells function," Dr. Bryant stated.

Why are these immune patterns consistent across different patients?

The study found that the observed immune defects remained consistent regardless of sex or whether the individual was newly diagnosed or managing the condition with a gluten-free diet. This suggests the differences are not simply a byproduct of inflammation or dietary intake, but may be linked to underlying genetic risk.

Snow Centre Director Professor Jason Tye Din, who provided clinical input for the research, noted that the Cyton2 Cell Timer is instrumental in revealing these hidden patterns. The consistency of these findings across diverse cohorts indicates that the behavior of these cells is a fundamental characteristic of the individuals studied.

"This gives us a new way to understand immune behaviour in greater detail. My hope is that these fundamental insights will eventually translate into clinically useful tools to inform assessments of disease risk," Professor Tye Din said.

Pro Tip: Understanding the difference between “overactive” immune responses and “defective” immune regulation is a growing area of focus in modern immunology, potentially shifting how we approach early detection for various autoimmune conditions.

What are the future implications for autoimmune disease detection?

While the current approach is a research tool, it highlights the potential for combining genetic data with functional immune measurements. Since many autoimmune conditions share overlapping genetic risk factors and affect approximately five percent of the population, these findings may eventually extend beyond coeliac disease.

“The Last Thing I Wanted To Do Was Upset Anybody” Vanessa Feltz Speaks Out After Coeliac Disease Row

The research team is currently investigating whether similar immune patterns exist in other autoimmune conditions and at what stage of life these differences appear. Professor Tye Din emphasized that the long-term goal of the team is to understand autoimmune risk with enough precision to intervene earlier, potentially before the disease fully develops.

Frequently Asked Questions

What is "immune momentum"?
It is a novel concept used by researchers to measure how well T cells store and process activation signals after the initial stimulus is removed, rather than just observing them during continuous stimulation.

Frequently Asked Questions

Does a gluten-free diet change these immune cell defects?
According to the study, the observed immune patterns were consistent regardless of whether the individuals were newly diagnosed or currently managing coeliac disease with a gluten-free diet.

Could this lead to a clinical test?
The researchers view this as a potential pathway for future risk prediction and personalized monitoring, though it currently remains a research tool used in laboratory settings.

Are these findings only relevant to coeliac disease?
The team believes the findings could have broader implications, as they are now investigating whether similar immune patterns appear in other autoimmune conditions that share genetic risk factors.


Do you have questions about how immune cell function impacts long-term health? Join the conversation in the comments below or subscribe to our newsletter for the latest updates on immune health research.

You may also like

Leave a Comment